Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : Nstg save search
NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
| Email alert
Add to watchlist
conference association cancer research
Cancer/Tumor Profiling Market worth $16.0 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published: 2022-11-08 (Crawled : 16:00) - prnewswire.com
TMO | News | $543.895 0.44% 830K
|
Health Technology
|
| O: 0.44%
H: 1.31%
C: -0.42%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 4.08%
H: 3.3%
C: 1.47%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 4.08%
H: 3.3%
C: 1.47%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -17.68%
H: 2.9%
C: -18.05%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.37%
H: 2.1%
C: 0.02%
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: -1.01%
H: 7.06%
C: 3.06%
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
|
| O: -0.85%
H: 1.54%
C: -5.24%
report market cancer
Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: 2.19%
H: 3.08%
C: 2.37%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.21%
H: 4.59%
C: 3.64%
cancer breast cancer
Global Spatial OMICS Market: Driven by the growing potential of spatial OMICS as a cancer diagnostic tool and increasing adoption of spatial OMICS in drug discovery and development |CAGR: 10.3%: Astute Analytica
Published: 2022-03-25 (Crawled : 12:00) - prnewswire.com
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.55%
H: 0.14%
C: -1.96%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -4.4%
diagnostic drug potential cancer growing
Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
Published: 2022-01-31 (Crawled : 14:30) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: 0.74%
H: 11.95%
C: 11.47%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.53%
H: 6.93%
C: 6.86%
symposium asco cancer
New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
Published: 2022-01-24 (Crawled : 14:30) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -3.0%
H: 11.05%
C: 10.59%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -2.39%
H: 10.58%
C: 9.87%
treatment genomic cel lung cancer cancer
Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test
Published: 2021-11-24 (Crawled : 12:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -7.87%
H: 2.7%
C: 1.81%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
europe expansion test cancer breast cancer
NanoString Launches nCounter TCR Diversity Panel and Analysis Package at the 2021 Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-11-11 (Crawled : 12:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 4.12%
H: 5.61%
C: 5.09%
immunotherapy therapy cancer
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
Published: 2021-11-05 (Crawled : 13:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -0.42%
H: 0.21%
C: -4.44%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -0.76%
H: 1.54%
C: 0.55%
test cancer
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: 2.48%
H: 2.57%
C: 2.4%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -3.2%
H: 5.64%
C: 5.05%
genomic cancer diagnostic
New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
treatment prostate cancer genomic cancer
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer
Published: 2021-10-25 (Crawled : 18:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -0.39%
H: 1.56%
C: -0.67%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.34%
H: 0.32%
C: -1.4%
risk prostate cancer test genomic cancer
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment
Published: 2021-10-11 (Crawled : 13:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -7.34%
H: 3.37%
C: 0.63%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -8.34%
H: 1.76%
C: -0.29%
lung cancer test cancer
New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease
Published: 2021-10-06 (Crawled : 14:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -0.81%
H: 1.86%
C: -1.02%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -1.58%
H: 4.16%
C: -0.53%
disease lung cancer test genomic cancer diagnostic
New Analysis from Global Industry Analysts Reveals Steady Growth for Cancer/Tumor Profiling, with the Market to Reach $10.7 Billion Worldwide by 2026
Published: 2021-09-07 (Crawled : 14:15) - prnewswire.com
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -0.71%
H: 1.13%
C: -1.99%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.27%
H: 0.03%
C: -0.87%
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: 0.78%
H: 0.92%
C: -1.85%
cancer growth
NanoString’s GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell
Published: 2021-08-31 (Crawled : 12:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.86%
H: 0.09%
C: -0.51%
cancer
NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
Published: 2021-06-15 (Crawled : 12:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.28%
H: 1.22%
C: -2.84%
immunotherapy therapy cancer collaboration
New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer
Published: 2021-06-14 (Crawled : 13:15) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: 0.66%
H: 4.76%
C: 2.39%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 1.25%
H: 2.35%
C: 1.05%
prostate cancer genomic cancer
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
Published: 2021-06-01 (Crawled : 12:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: 0.31%
H: 1.58%
C: -6.56%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.0%
H: 2.43%
C: -3.59%
cancer growth diagnostics positive diagnostic
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
Published: 2021-05-26 (Crawled : 14:00) - biospace.com/
VCYT | $19.18 -0.1% 470K
|
Health Technology
|
| O: -0.1%
H: 6.03%
C: 5.73%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -0.19%
H: 1.52%
C: 1.27%
cancer
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
PAPL | $1.435 -12.5% 1.1M
|
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.